Dirk J. Jager
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 366 publications
Evaluating an innovative support programme for older long-term cancer survivors (IMPULS-A): protocol for a randomised controlled trial.
Journal: BMJ open
Published: September 01, 2026
PRAME-Specific T-Cell Therapy in Advanced Pediatric Nephroblastoma.
Journal: The New England journal of medicine
Published: August 12, 2026
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: June 19, 2026
Hierarchical classification of immune cell transcriptomes at population-scale.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scale.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Patient-specific subperiosteal implant for the treatment of upper denture retention problems
Journal: Nederlands tijdschrift voor tandheelkunde
Published: March 04, 2026
Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Rising incidence of carbapenem-resistant Citrobacter spp. in a German tertiary-care hospital: epidemiology, clinical impact, and the role of the hospital wastewater system-findings from a six-year molecular study.
Journal: Microbiology spectrum
Published: January 22, 2026
Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II Trial.
Journal: International journal of cancer
Published: January 17, 2026
Last Updated: 09/26/2026